Michael L Christensen1, Phil Ayers2, Joseph I Boullata3, Peggi Guenter4, Kathleen M Gura5, Beverly Holcombe4, David S Seres6, Gordon S Sacks7. 1. 1 Departments of Clinical Pharmacy and Pediatrics, University of Tennessee Health Science Center Memphis, Memphis, Tennessee, USA. 2. 2 Clinical Pharmacy Services, Baptist Health Systems Department of Pharmacy, Jackson, Mississippi, USA. 3. 3 Clinical Nutrition Support Services, Hospital of the University of Pennsylvania and Drexel University Philadelphia, Pennsylvania, USA. 4. 4 American Society for Parenteral and Enteral Nutrition, Silver Spring, Maryland, USA. 5. 5 Clinical Research, Department of Pharmacy, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. 6. 6 Institute of Human Nutrition, Division of Preventive Medicine and Nutrition Department of Medicine Columbia University Medical Center, New York, New York, USA; and. 7. 7 Department of Pharmacy Practice, Auburn University, Auburn, Alabama, USA.
Abstract
BACKGROUND: Lipid injectable emulsion (ILE) is an integral part of parenteral nutrition (PN), providing energy and essential fatty acids. With recent consensus recommendations for PN, clinical guidelines for ordering and preparation of PN, the U.S. Food and Drug Administration approval of new ILE products, and revised ILE labeling to include a 1.2-micron filter, a gap in current practice knowledge was apparent. MATERIALS AND METHODS: The American Society for Parenteral and Enteral Nutrition PN Safety Committee surveyed clinicians on how ILE products are prescribed, prepared, and administered to patients from neonates to adults. RESULTS: The results of this survey conducted in late 2016 found a wide variation in practice, particularly across patient age groups. CONCLUSION: These findings demonstrate the need for ongoing dissemination and education on standardized safe practices for ILE use.
BACKGROUND:Lipid injectable emulsion (ILE) is an integral part of parenteral nutrition (PN), providing energy and essential fatty acids. With recent consensus recommendations for PN, clinical guidelines for ordering and preparation of PN, the U.S. Food and Drug Administration approval of new ILE products, and revised ILE labeling to include a 1.2-micron filter, a gap in current practice knowledge was apparent. MATERIALS AND METHODS: The American Society for Parenteral and Enteral Nutrition PN Safety Committee surveyed clinicians on how ILE products are prescribed, prepared, and administered to patients from neonates to adults. RESULTS: The results of this survey conducted in late 2016 found a wide variation in practice, particularly across patient age groups. CONCLUSION: These findings demonstrate the need for ongoing dissemination and education on standardized safe practices for ILE use.
Authors: Roland N Dickerson; Vanessa J Kumpf; Angela L Bingham; Allison B Blackmer; Todd W Canada; Lingtak-Neander Chan; Sarah V Cogle; Anne M Tucker Journal: Hosp Pharm Date: 2018-05-30